Randomization and Trial Supply Management (RTSM) systems address study specific needs for patient randomization and medication management, while clinical supply management systems help pharmaceutical companies manage all clinical products at the enterprise level. Typically separate from one another, Signant is pioneering a “free picking” interface solution that connects the two in order to create a drug pooling study product supply model. Using this approach, sponsors can make investigational products available across studies and programs, enabling significant product and cost efficiencies while significantly reducing waste. Signant’s Bart Nicholson explains how the solution works in detail and the benefits sponsors can achieve.